Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Cramer

Showing results (71-80 of 233) with videos related to

Pageof 24
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2023
Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone LevelsDaniel W Cramer, Allison F Vitonis, Tianyi Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2012
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer riskKathryn L Terry, Shelley S Tworoger, Allison F Vitonis, et al.
International Journal of Cancer|January 1, 2009
Flavonoid intake and ovarian cancer risk in a population-based case-control studyMargaret A Gates, Allison F Vitonis, Shelley S Tworoger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancerDaniel W Cramer, Linda Titus-Ernstoff, John R McKolanis, et al.
Cancer Causes & Control : CCC|August 9, 2013
Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer riskDaniel W Cramer, Kristina Williams, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health StudiesSimone P Pinheiro, Susan E Hankinson, Shelley S Tworoger, et al.
International Journal of Cancer|May 8, 2013
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control StudyMegan S Rice, Megan A Murphy, Allison F Vitonis, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigensJoshua R Ehrlich, Liangdan Tang, Robert J Caiazzo, et al.
Ultrastructural Pathology|March 23, 2019
Correlative polarizing light and scanning electron microscopy for the assessment of talc in pelvic region lymph nodesSandra A McDonald, Yuwei Fan, William R Welch, et al.
International Journal of Cancer|November 1, 2008
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populationsMargaret A Gates, Shelley S Tworoger, Kathryn L Terry, et al.
Pageof 24

Showing results (71-80 of 233) with videos related to

Sort By:
Pageof 24
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 2023
Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone LevelsDaniel W Cramer, Allison F Vitonis, Tianyi Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2012
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer riskKathryn L Terry, Shelley S Tworoger, Allison F Vitonis, et al.
International Journal of Cancer|January 1, 2009
Flavonoid intake and ovarian cancer risk in a population-based case-control studyMargaret A Gates, Allison F Vitonis, Shelley S Tworoger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancerDaniel W Cramer, Linda Titus-Ernstoff, John R McKolanis, et al.
Cancer Causes & Control : CCC|August 9, 2013
Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer riskDaniel W Cramer, Kristina Williams, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health StudiesSimone P Pinheiro, Susan E Hankinson, Shelley S Tworoger, et al.
International Journal of Cancer|May 8, 2013
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control StudyMegan S Rice, Megan A Murphy, Allison F Vitonis, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigensJoshua R Ehrlich, Liangdan Tang, Robert J Caiazzo, et al.
Ultrastructural Pathology|March 23, 2019
Correlative polarizing light and scanning electron microscopy for the assessment of talc in pelvic region lymph nodesSandra A McDonald, Yuwei Fan, William R Welch, et al.
International Journal of Cancer|November 1, 2008
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populationsMargaret A Gates, Shelley S Tworoger, Kathryn L Terry, et al.
Pageof 24